Qiagen NV
(WBO:QGE2)
€
40.99
0.19 (0.47%)
Market Cap: 9.14 Bil
Enterprise Value: 9.61 Bil
PE Ratio: 138.52
PB Ratio: 2.87
GF Score: 87/100 
Qiagen NV at TD Cowen Health Care Conference Transcript
Mar 05, 2024 / 02:10PM GMT
Release Date Price:
€40.77
(+1.19%)
Daniel Gregory Brennan
TD Cowen, Research Division - MD and Senior Tools & Diagnostics Analyst
Day 2 of the TD Cowen Global Healthcare Conference, Dan Brennan, follow tools and diagnostics. Really pleased to be joined here on the stage with me, management of QIAGEN. To my left, we have Roland Sackers, who is the CFO, and we have to his left, John Gilardi, who is Investor Relations. So gentlemen, welcome.
Roland Sackers
Qiagen N.V. - CFO, MD & Member of Management Board
Thanks.
Questions & Answers
Daniel Gregory Brennan
TD Cowen, Research Division - MD and Senior Tools & Diagnostics Analyst
We were pleased to have you guys. A lot to tackle here. Maybe kind of -- well, let's just kick it off with Roland, you want to give us a quick backdrop on kind of Q4, maybe just look ahead to '24, kind of how you thought about the year went and maybe what are you excited about for 24?
Roland Sackers
Qiagen N.V. - CFO, MD & Member of Management Board
Yes.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers